Published in J Hosp Infect on May 01, 1991
Clinical impact of abnormal gut flora in infants receiving parenteral nutrition. Ann Surg (1998) 0.88
Thrombocytopenia and bacterial sepsis in neonates. Indian J Hematol Blood Transfus (2011) 0.77
Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother (1977) 3.32
Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group. Lancet (1992) 2.89
Resistance of Escherichia coli to penicillins. V. Physiological comparison of two isogenic strains, one with chromosomally and one with episomally mediated ampicillin resistance. J Bacteriol (1968) 2.27
Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children. J Infect Dis (1984) 2.19
Ecological impact of ampicillin and cefuroxime in neonatal units. Lancet (1989) 2.11
Molecular model for elongation of the murein sacculus of Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.97
Resistance of Escherichia coli to penicillins: fine-structure mapping and dominance of chromosomal beta-lactamase mutations. J Bacteriol (1977) 1.96
Colicin tolerance induced by ampicillin or mutation to ampicillin resistance in a strain of Escherichia coli K-12. J Bacteriol (1971) 1.96
Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol (1972) 1.95
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84
Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis (1991) 1.75
Evidence for diffuse growth of the cylindrical portion of the Escherichia coli murein sacculus. J Bacteriol (1983) 1.71
Autolysis of Neisseria gonorrhoeae. J Bacteriol (1976) 1.65
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol (2004) 1.62
Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology (1999) 1.61
Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J Bacteriol (1970) 1.52
The prepuce: a mistake of nature? Lancet (1989) 1.52
Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase. J Bacteriol (1973) 1.49
Correlation between surface and air counts of particles carrying aerobic bacteria in operating rooms with turbulent ventilation: an experimental study. J Hosp Infect (1999) 1.45
Changes in the composition of Escherichia coli murein as it ages during exponential growth. J Bacteriol (1983) 1.43
Relation between nursing procedures, other local characteristics and transmission of enteric bacteria in neonatal wards. J Hosp Infect (1993) 1.39
Biochemical fingerprinting compared with ribotyping and pulsed-field gel electrophoresis of DNA for epidemiological typing of enterococci. J Clin Microbiol (1995) 1.38
Evidence for multisite growth of Escherichia coli murein involving concomitant endopeptidase and transpeptidase activities. J Bacteriol (1983) 1.38
Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol (1988) 1.36
Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microb Drug Resist (2003) 1.25
Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25
Time- and media-saving testing and identification of microorganisms by multipoint inoculation on undivided agar plates. J Clin Microbiol (1978) 1.25
Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun (2000) 1.23
Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy. Antimicrob Agents Chemother (1992) 1.20
Amplification of sex repressor function of one fi-+ R-factor during anaerobic growth of Escherichia coli. J Bacteriol (1975) 1.13
An allelic variant of the chromosomal gene for class A beta-lactamase K2, specific for Klebsiella pneumoniae, is the ancestor of SHV-1. Antimicrob Agents Chemother (1997) 1.12
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect (2009) 1.12
Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr (1996) 1.10
Colonization and persistence of Escherichia coli phenotypes in the intestines of children aged 0 to 18 months. Infection (1986) 1.10
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immun (2007) 1.09
Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.08
Molecular cloning in streptococci: physical mapping of the vehicle plasmid pSM10 and demonstration of intergroup DNA transfer. Mol Gen Genet (1981) 1.06
R-plasmid transfer and its response to nalidixic acid. J Bacteriol (1977) 1.04
Ureaplasma urealyticum-induced production of proinflammatory cytokines by macrophages. Pediatr Res (2000) 1.01
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol (2008) 1.01
Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol (1999) 1.00
Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli. J Med Microbiol (1992) 0.99
Novel coagglutination method for serotyping group B streptococci. J Clin Microbiol (1992) 0.99
The use of colonization rate and epidemic index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in Swedish neonatal wards. J Hosp Infect (1993) 0.98
Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis (1988) 0.98
Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. J Hosp Infect (1988) 0.97
Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection. Eur J Clin Microbiol Infect Dis (1988) 0.97
Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic ward. Epidemiol Infect (1990) 0.96
Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice. Clin Exp Immunol (2003) 0.95
Elongation of the murein sacculus of Escherichia coli. Ann Inst Pasteur Microbiol (1985) 0.93
Nationwide spread of Klebsiella oxytoca K55 in Swedish neonatal special care wards. APMIS (1992) 0.93
Diagnostic performance of urine dipstick testing in children with suspected UTI: a systematic review of relationship with age and comparison with microscopy. Acta Paediatr (2010) 0.93
Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr (2000) 0.92
Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Example of an ongoing project within the European research programme. Int J Antimicrob Agents (2000) 0.92
Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother (1987) 0.92
Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J Urol (1997) 0.91
Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile. J Hosp Infect (2003) 0.91
B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. Arch Dis Child (2007) 0.90
Expression of R-plasmid functions during anaerobic growth of an Escherichia coli K-12 host. J Bacteriol (1977) 0.90
Urinary tract infection in primary health care in northern Sweden. I. Epidemiology. Scand J Prim Health Care (1987) 0.90
P-fimbriae studies on the diagnosis and prevention of acute pyelonephritis. Infection (1985) 0.90
Recurrent pneumonia and encephalitis due to Mycoplasma pneumoniae. Scand J Infect Dis (1979) 0.90
Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Am J Transplant (2009) 0.88
Anaerobic phagocytosis, killing, and degradation of Streptococcus pneumoniae by human peripheral blood leukocytes. Infect Immun (1985) 0.88
Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis. Pediatr Nephrol (1994) 0.87
A 7-year survey of drug resistance in aerobic and anaerobic fecal bacteria of surgical inpatients: clinical relevance and relation to local antibiotic consumption. Scand J Infect Dis (1989) 0.87
Urinary tract infection in primary health care in northern Sweden. II. Clinical presentation. Scand J Prim Health Care (1987) 0.86
Aerobactin-mediated uptake of iron by strains of Escherichia coli causing acute pyelonephritis and bacteraemia. J Infect (1988) 0.86
Epidemiological aspects of P-fimbriated E. coli. II. Variations in incidence of E. coli infections in children attending a neonatal ward. Acta Paediatr Scand (1986) 0.86
Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages. Infect Immun (2000) 0.86
Influence of antibiotic therapy on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in neonates. J Antimicrob Chemother (1988) 0.85
Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime. Antimicrob Agents Chemother (1990) 0.85
Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. J Clin Immunol (2012) 0.85
Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up. Pediatr Radiol (1994) 0.85
Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid. Antimicrob Agents Chemother (2006) 0.85
Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice. Clin Exp Immunol (2000) 0.85
Pathogenesis of Escherichia coli cystitis and pyelonephritis: apparent lack of significance of bacterial motility and chemotaxis towards human urine. Infection (1985) 0.85
Transferable and non-transferable drug resistance in enteric bacteria isolated from urinary specimens in Northern Sweden. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.85
Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. Lupus (2011) 0.84
Efficient transfer of conjugative plasmids by multipoint inoculation and some observations on host range and prevalence of R plasmids. Plasmid (1978) 0.84
Transmission of urinary bacterial strains between patients with indwelling catheters--nursing in the same room and in separate rooms compared. J Hosp Infect (1997) 0.84
Importance of the environment and the faecal flora of infants, nursing staff and parents as sources of gram-negative bacteria colonizing newborns in three neonatal wards. Infection (1992) 0.84
Cell surface hydrophobicity, adherence to HeLa cell cultures and haemagglutination pattern of pyelonephritogenic Escherichia coli strains. Epidemiol Infect (1990) 0.84
Initiation of clinical pyelonephritis--the role of P-fimbriae-mediated bacterial adhesion. Contrib Nephrol (1984) 0.84
Significance of the sulfonamide component for the clinical efficacy of trimethoprim-sulfonamide combinations. Scand J Infect Dis (1986) 0.83
Fecal colonization with pyelonephritogenic Escherichia coli in neonates as a risk factor for pyelonephritis. Eur J Clin Microbiol (1986) 0.83
Production of cytotoxic necrotizing factor, verocytotoxin and haemolysin by pyelonephritogenic Escherichia coli. Eur J Clin Microbiol Infect Dis (1990) 0.83
Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Acta Anaesthesiol Scand (2007) 0.83
Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand (2002) 0.83
Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit. Acta Paediatr (1998) 0.83
Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile. Antimicrob Agents Chemother (2007) 0.82
Uricult and Sensicult dipslides for diagnosis of bacteriuria and prediction of drug resistance in primary health care. Scand J Prim Health Care (1989) 0.82
Urinary tract infection in primary health care in northern Sweden. III. Bacteriology in relation to clinical and epidemiological factors. Scand J Prim Health Care (1987) 0.82